 MINNEAPOLIS, March 08, 2022 GLOBE NEWSWIRE -- Panbela Therapeutics, Inc. Nasdaq: PBLA, a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced that it will host a conference call on March 24, 2022 at 4:30 PM Eastern Time to discuss results for its fourth quarter ended December 31, 2021. 